vs
礼来（RNA）与UNIVERSAL HEALTH REALTY INCOME TRUST（UHT）财务数据对比。点击上方公司名可切换其他公司
UNIVERSAL HEALTH REALTY INCOME TRUST的季度营收约是礼来的2.0倍（$24.5M vs $12.5M），UNIVERSAL HEALTH REALTY INCOME TRUST净利率更高（17.7% vs -1398.3%，领先1416.0%），礼来同比增速更快（434.0% vs -0.7%），过去两年礼来的营收复合增速更高（138.5% vs -1.3%）
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
环球健康服务公司（UHS）是一家总部位于宾夕法尼亚州普鲁士国王市的美国医疗服务企业，位列财富500强，主营医院运营及各类医疗保健服务。该公司2024年公布的总营收达158亿美元。
RNA vs UHT — 直观对比
营收规模更大
UHT
是对方的2.0倍
$12.5M
营收增速更快
RNA
高出434.7%
-0.7%
净利率更高
UHT
高出1416.0%
-1398.3%
两年增速更快
RNA
近两年复合增速
-1.3%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $12.5M | $24.5M |
| 净利润 | $-174.4M | $4.3M |
| 毛利率 | — | — |
| 营业利润率 | -1513.5% | 34.7% |
| 净利率 | -1398.3% | 17.7% |
| 营收同比 | 434.0% | -0.7% |
| 净利润同比 | -117.0% | -7.2% |
| 每股收益（稀释后） | $-1.27 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RNAUHT
| Q4 25 | — | $24.5M | ||
| Q3 25 | $12.5M | $25.3M | ||
| Q2 25 | $3.8M | $24.9M | ||
| Q1 25 | $1.6M | $24.5M | ||
| Q4 24 | $3.0M | $24.6M | ||
| Q3 24 | $2.3M | $24.5M | ||
| Q2 24 | $2.0M | $24.7M | ||
| Q1 24 | $3.5M | $25.1M |
净利润RNAUHT
| Q4 25 | — | $4.3M | ||
| Q3 25 | $-174.4M | $4.0M | ||
| Q2 25 | $-157.3M | $4.5M | ||
| Q1 25 | $-115.8M | $4.8M | ||
| Q4 24 | $-102.3M | $4.7M | ||
| Q3 24 | $-80.4M | $4.0M | ||
| Q2 24 | $-70.8M | $5.3M | ||
| Q1 24 | $-68.9M | $5.3M |
营业利润率RNAUHT
| Q4 25 | — | 34.7% | ||
| Q3 25 | -1513.5% | 33.2% | ||
| Q2 25 | -4448.7% | 35.6% | ||
| Q1 25 | -8360.9% | 36.8% | ||
| Q4 24 | -4069.6% | 37.6% | ||
| Q3 24 | -4200.9% | 34.7% | ||
| Q2 24 | -4040.4% | 38.7% | ||
| Q1 24 | -2178.6% | 37.6% |
净利率RNAUHT
| Q4 25 | — | 17.7% | ||
| Q3 25 | -1398.3% | 15.9% | ||
| Q2 25 | -4089.3% | 18.1% | ||
| Q1 25 | -7360.0% | 19.5% | ||
| Q4 24 | -3439.5% | 18.9% | ||
| Q3 24 | -3441.7% | 16.3% | ||
| Q2 24 | -3461.8% | 21.3% | ||
| Q1 24 | -1943.4% | 21.1% |
每股收益（稀释后）RNAUHT
| Q4 25 | — | $0.32 | ||
| Q3 25 | $-1.27 | $0.29 | ||
| Q2 25 | $-1.21 | $0.32 | ||
| Q1 25 | $-0.90 | $0.34 | ||
| Q4 24 | $-0.80 | $0.34 | ||
| Q3 24 | $-0.65 | $0.29 | ||
| Q2 24 | $-0.65 | $0.38 | ||
| Q1 24 | $-0.79 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $350.2M | $6.7M |
| 总债务越低越好 | — | $374.8M |
| 股东权益账面价值 | $1.9B | $152.4M |
| 总资产 | $2.1B | $564.9M |
| 负债/权益比越低杠杆越低 | — | 2.46× |
8季度趋势，按日历期对齐
现金及短期投资RNAUHT
| Q4 25 | — | $6.7M | ||
| Q3 25 | $350.2M | $6.9M | ||
| Q2 25 | $243.9M | $6.6M | ||
| Q1 25 | $254.2M | $7.0M | ||
| Q4 24 | $219.9M | $7.1M | ||
| Q3 24 | $370.2M | $6.4M | ||
| Q2 24 | $575.8M | $5.6M | ||
| Q1 24 | $471.4M | $7.7M |
总债务RNAUHT
| Q4 25 | — | $374.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $368.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益RNAUHT
| Q4 25 | — | $152.4M | ||
| Q3 25 | $1.9B | $158.6M | ||
| Q2 25 | $1.2B | $165.2M | ||
| Q1 25 | $1.3B | $172.2M | ||
| Q4 24 | $1.4B | $179.5M | ||
| Q3 24 | $1.5B | $181.6M | ||
| Q2 24 | $1.2B | $190.7M | ||
| Q1 24 | $830.9M | $196.5M |
总资产RNAUHT
| Q4 25 | — | $564.9M | ||
| Q3 25 | $2.1B | $568.0M | ||
| Q2 25 | $1.4B | $573.0M | ||
| Q1 25 | $1.5B | $573.5M | ||
| Q4 24 | $1.6B | $580.9M | ||
| Q3 24 | $1.6B | $584.3M | ||
| Q2 24 | $1.3B | $586.6M | ||
| Q1 24 | $951.5M | $596.2M |
负债/权益比RNAUHT
| Q4 25 | — | 2.46× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.05× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-156.2M | $49.1M |
| 自由现金流经营现金流 - 资本支出 | $-156.9M | — |
| 自由现金流率自由现金流/营收 | -1257.6% | — |
| 资本支出强度资本支出/营收 | 5.7% | — |
| 现金转化率经营现金流/净利润 | — | 11.35× |
| 过去12个月自由现金流最近4个季度 | $-592.3M | — |
8季度趋势，按日历期对齐
经营现金流RNAUHT
| Q4 25 | — | $49.1M | ||
| Q3 25 | $-156.2M | $10.2M | ||
| Q2 25 | $-199.7M | $13.7M | ||
| Q1 25 | $-124.8M | $11.6M | ||
| Q4 24 | $-99.9M | $46.9M | ||
| Q3 24 | $-65.6M | $9.9M | ||
| Q2 24 | $-65.0M | $12.1M | ||
| Q1 24 | $-70.4M | $11.7M |
自由现金流RNAUHT
| Q4 25 | — | — | ||
| Q3 25 | $-156.9M | — | ||
| Q2 25 | $-203.0M | — | ||
| Q1 25 | $-128.6M | — | ||
| Q4 24 | $-103.8M | — | ||
| Q3 24 | $-67.3M | — | ||
| Q2 24 | $-65.5M | — | ||
| Q1 24 | $-71.3M | — |
自由现金流率RNAUHT
| Q4 25 | — | — | ||
| Q3 25 | -1257.6% | — | ||
| Q2 25 | -5277.1% | — | ||
| Q1 25 | -8174.3% | — | ||
| Q4 24 | -3491.0% | — | ||
| Q3 24 | -2881.8% | — | ||
| Q2 24 | -3204.6% | — | ||
| Q1 24 | -2012.3% | — |
资本支出强度RNAUHT
| Q4 25 | — | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 86.9% | — | ||
| Q1 25 | 238.6% | — | ||
| Q4 24 | 131.7% | — | ||
| Q3 24 | 72.9% | — | ||
| Q2 24 | 26.0% | — | ||
| Q1 24 | 25.8% | — |
现金转化率RNAUHT
| Q4 25 | — | 11.35× | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | 3.05× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | — | 10.06× | ||
| Q3 24 | — | 2.48× | ||
| Q2 24 | — | 2.30× | ||
| Q1 24 | — | 2.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RNA
暂无分部数据
UHT
| Reportable Segment Aggregation Before Other Operating Segment | $23.1M | 94% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $2.3M | 9% |
